Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control by Wajja, A, Nassanga, B, Natukunda, A, Serubanja, J, Tumusiime, J, Akurut, H, Oduru, G, Nassuuna, J, Kabagenyi, J, Morrison, H, Scott, H, Powell Doherty, R, Marshall, JL, Cabrera Puig, I, Cose, S, Kaleebu, P, Webb, EL, Satti, I, McShane, H, Elliott, AM

Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-... by Satti, I, Marshall, JL, Harris, SA, Wittenberg, R, Tanner, R, Lopez Ramon, R, Wilkie, M, Ramos Lopez, F, Riste, M, Wright, D, Peralta Alvarez, MP, Williams, N, Morrison, H, Stylianou, E, Folegatti, P, Jenkin, D, Vermaak, S, Rask, L, Cabrera Puig, I, Powell Doherty, R, Lawrie, A, Moss, P, Hinks, T, Bettinson, H, McShane, H

Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 contro... by Jackson, S, Marshall, JL, Mawer, A, Lopez-Ramon, R, Harris, SA, Satti, I, Hughes, E, Preston-Jones, H, Cabrera Puig, I, Longet, S, Tipton, T, Laidlaw, S, Doherty, RP, Morrison, H, Mitchell, R, Tanner, R, Ateere, A, Stylianou, E, Wu, M-S, Fredsgaard-Jones, TPW, Breuer, J, Rapeport, G, Ferreira, VM, Gleeson, F, Pollard, AJ, Carroll, M, Catchpole, A, Chiu, C, McShane, H, Alparaque, M, Anid, L, Barnes, E, Benamore, R, Bharti, N, Patel, B, Burns, A, Byard, N, Conway, O, Cooper, C, Crowther, C, Dunachie, SJ, Johnstone, T, Jose, J, Luciw, M, Mujadidi, Y, Nehiweze, A, Nyamunda, S, Orobiyi-Rieba, M, Parvelikudy, B, Platt, A